InsiderSignalSign in

← Insider buys

XOMA

XOMA Royalty Corp · Healthcare

Insiders bought $2.5M of XOMA Royalty Corp in the last 12 months

1 insider bought on 1 day.

$2.5MBought, 12 mo

$0Sold, 12 mo

$710.2MMarket cap

XOMA over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

Owen HughesCEO · 1 day$2.5M

XOMA after insider buys

3 months after each buy, from the first price a copier could get.

+23.8%Average

+17.3 ptsVs S&P 500

12 of 16Higher

16 buys since 2018 with 3 months of prices.

Every filing

56 insider filings since 2016, newest first

Owen Hughes · CEO

$2.5M+99.0%Dec 8

Bradley Sitko · Chief Investment Officer

Bradley Sitko · Chief Investment Officer

$49K+10.0%Apr 9

Bradley Sitko · Chief Investment Officer

Thomas M. Burns · SVP, Finance, CFO

Bradley Sitko · Chief Investment Officer

$99K+29.0%Mar 25

Thomas M. Burns · SVP, Finance, CFO

$293K−30.0%Nov 13

Owen Hughes · CEO

$655K−37.0%Nov 13

Owen Hughes · Exec COB, Interim CEO

$36K+125.0%Sep 27

Bradley Sitko · Chief Investment Officer

$26K+26.0%Jun 2

Bradley Sitko · Chief Investment Officer

Bvf Partners L P/il · 10% owner

$421K+1.0%Jan 9

Bvf Partners L P/il · 10% owner

$409K+1.0%Sep 27

Bvf Partners L P/il · 10% owner

$991K+3.0%Sep 16

Thomas M. Burns · SVP, Finance, CFO

$63K−13.0%Jul 18

James R Neal · CEO

$746K−43.0%Jul 18

James R Neal · CEO

$1.6M−62.0%Mar 23

Thomas M. Burns · SVP, Finance, CFO

$423K−51.0%Mar 23

James R Neal · CEO

$303K−22.0%Jun 29

Bvf Partners L P/il · 10% owner

$25.0M−60.0%Apr 2

James R Neal · CEO

$1.1M−44.0%Dec 17

Thomas M. Burns · SVP, Finance, CFO

$621K−55.0%Dec 17

Matthew D Perry · Insider

Bvf Partners L P/il · 10% owner

$5.0M+5.0%Dec 15

James R Neal · CEO

$656K−44.0%Nov 24

Thomas M. Burns · SVP, Finance, CFO

$392K−54.0%Nov 24

James R Neal · CEO

$260K−28.0%Nov 6

Thomas M. Burns · SVP, Finance, CFO

$209K−44.0%Nov 6

Bvf Partners L P/il · 10% owner

$666K+2.0%Sep 1

Bvf Partners L P/il · 10% owner

$547K+1.0%Aug 25

Bvf Partners L P/il · 10% owner

Bvf Partners L P/il · 10% owner

$499K+1.0%Aug 14

Bvf Partners L P/il · 10% owner

Bvf Partners L P/il · 10% owner

Bvf Partners L P/il · 10% owner

$2.1M+4.0%Mar 17

James R Neal · CEO

$96K−17.0%Nov 8

James R Neal · CEO

$329K−42.0%Sep 20

Thomas M. Burns · SVP, Finance, CFO

$173K−47.0%Sep 20

Bvf Partners L P/il · 10% owner

$408K+2.0%May 14

Bvf Partners L P/il · 10% owner

$355K+1.0%Dec 19

Bvf Partners L P/il · 10% owner

$527K+2.0%Dec 13

Bvf Partners L P/il · 10% owner

$897K+4.0%Dec 10

Bvf Partners L P/il · 10% owner

$146K+1.0%Dec 4

Bvf Partners L P/il · 10% owner

$448K+2.0%Nov 29

Bvf Partners L P/il · 10% owner

$1.0M+5.0%Nov 21

Bvf Partners L P/il · 10% owner

$431K+2.0%Nov 19

Ness W Denman Van · Director

$70K−37.0%Nov 16

James R Neal · CEO

$53K+21.0%Nov 15

Thomas M. Burns · SVP, Finance, CFO

$272K−55.0%Apr 27

James R Neal · CEO

$588K−55.0%Apr 27

About XOMA Royalty Corp

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.